$MRVL

Cantor Fitzgerald maintains Marvell Technology at Neutral, lowers price target to $225 from $350

Cantor Fitzgerald kept its Neutral rating on Marvell Technology but cut its price target to $225 from $350, a 35.7% reduction. This implies a 31.3% upside from the Nov 2 close of $171.41. Recent analyst price targets for the company range from $225 to $450.

Original reporting
Published Nov 3, 2026, 11:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 12:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cantor Fitzgerald maintains Marvell Technology at Neutral, lowers price target to $225 from $350 — source image
Decision brief

The 30-second read

$MRVLBearishMed
01

Why it matters

The target reduction could trigger sell pressure and affect related semiconductor stocks.

02

Market read

Analyst target cuts are a common catalyst for short-term price moves in the affected stock.

03

What to watch

Potential upside from upcoming product launches or contract wins not reflected in the target.

Relevance 7/10Novelty 5/10Timing: today

Background

Cantor Fitzgerald's analyst note is part of routine coverage of Marvell Technology, a semiconductor company.

Company-level read

Ticker impact

$MRVLBearishHigh confidence
Context

Cantor Fitzgerald lowered its price target for Marvell Technology to $225 from $350, a 35.7% decrease.

Expected impact

likely downward pressure as investors price in the lower target

Evidence & confidence

Analyst target cuts often lead to short-term price declines, especially when the reduction is sizable.

Market effects

May weigh on semiconductor sector sentiment as a major analyst reduces outlook.

Limited to US and global tech investors tracking MRVL.

Minor impact beyond the semiconductor space.

Counterpoint

Some investors may view the cut as an overreaction and see buying opportunity.

Key entities

  • Marvell Technology

    US-listed semiconductor firm (ticker MRVL).

  • Cantor Fitzgerald

    Equity research firm providing the price target revision.

Related articles

$MRVLHighAI 9/10

Marvell and Lumentum Fell Hard. Their Supplier’s Stock Is Soaring

Marvell (MRVL) agreed to acquire Lumentum (LITE) in an all-stock deal, causing both stocks to drop. Fabrinet (FN), a supplier to both, reported record revenue and earnings, rising in after-hours trading. The deal implies an $11.5B enterprise value, with Marvell shareholders owning 67% of the combined company. Fabrinet's data center revenue grew 78%, but its margins remain thin.

$MRVLHigh

Analysts downgrade Marvell and slash price targets over Lumentum deal

TD Cowen and Bank of America downgraded Marvell Technology, citing concerns over its all-stock acquisition of Lumentum. TD Cowen cut its price target to $175 from $350, expecting EPS dilution. Bank of America reduced its target to $225 from $400, citing potential stock overhang and regulatory hurdles. Both analysts see strategic merit but question the timing and structure of the deal.

$MRVLHighAI 9/10

What Just Happened To Marvell Stock?

Marvell Technology (MRVL) shares dropped 12.7% on November 2, 2026, following its agreement to acquire Lumentum for an implied enterprise value of $115 billion, using its own stock. The acquisition values Lumentum at five times its price a year earlier. Marvell's decline was larger than its sector and peers, marking its third consecutive down day. The stock is down 37.0% over the month but up 93.9% over twelve months.

$MRVLMed

BofA Slashes Marvell Target by 44% After Lumentum Deal

Bank of America downgraded Marvell Technology to Neutral from Buy, cutting its price target to $225 from $400. The bank cited concerns over regulatory hurdles, share dilution, and potential customer conflicts related to Marvell's proposed acquisition of Lumentum. The deal, expected to close in early 2028, may not offset the estimated 50% increase in Marvell's share count with $1B in cost savings. The SOX index has fallen 19% over the past month.

$MRVLHighAI 9/10

Marvell Technology agreed to acquire Lumentum in an all-stock deal valued at $115 billion

Marvell Technology agreed to acquire Lumentum in an all-stock deal valued at $115 billion. Lumentum shareholders will receive 4.5 Marvell shares per share, a 23.9% premium. The deal aims to combine semiconductor and photonics technologies for AI data centers, with expected $1B annual cost savings. The transaction is subject to shareholder and regulatory approvals, expected to close in H1 2028. Marvell shares fell 12.7%, Lumentum 18.6% post-announcement.